L-theanine Blood Pressure Randomized Trial: What the Evidence Says

Quick Answer

L-theanine Blood Pressure Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 randomized trial, 1 observational study.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• The risk of NCDs such as diabetes and cardiovascular disease increases with aging due to a progressive decline in metabolic function. [Fuke Saeka (2026); evidence level 2]
• The World Health Organization identifies elevated blood glucose level and abnormal lipid profiles as key risk factors for NCDs. [Fuke Saeka (2026); evidence level 2]
• However, tinnitus is a heterogeneous condition with patients presenting a variety of overlapping symptoms and phenotypes related to the auditory component and the associated suffering characterized by psychological distress, sleep problems, concentration difficulties, behavioral changes, and functional impairment. [Cepeda Uceta Massiel (2026); evidence level 3]
• In a systematic review based on five randomized controlled trials (RCTs), it was concluded that a standardizedextract is an evidence-based treatment option in tinnitus. [Cepeda Uceta Massiel (2026); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For l-theanine blood pressure randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Fuke Saeka (2026). Effects of Green Tea–Intake Timing on Glucose and Lipid Metabolism in Older Adults: An 8‐Week Randomized Controlled Trial. DOI: 10.1155/jnme/2301278. PMCID: PMC13054514. PMID: 41952965. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13054514/
• Cepeda Uceta Massiel (2026). Benefits of a Natural Dietary Supplement for Tinnitus: An Observational Prospective Exploratory Study. DOI: 10.3390/audiolres16020048. PMCID: PMC13112986. PMID: 42041961. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13112986/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.